[The AGT genotype affects the antihypertensive effects of benazepril].

Author: LinShu-guang, LiuGuo-zhang, MaWe-jun, YuHui-min, ZhangYu-qing

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To investigate the association between M235T variant of angiotensinogen (AGT) gene and the blood pressure response to benazepril in a hypertensive cohort. METHODS: Benazepril (10-20 mg/day) was administered for 6 weeks to 251 essential hypertensives. Polymerase chain reaction (PCR) combi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/16266458

データ提供:米国国立医学図書館(NLM)

The AGT Genotype and Antihypertensive Effects of Benazepril: Tailoring Treatment to Individual Needs

This research explores the association between a specific variant in the angiotensinogen (AGT) gene, known as M235T, and the blood pressure response to benazepril, a common antihypertensive medication. The study involved 251 patients with essential hypertension who received benazepril for six weeks. The researchers analyzed the blood pressure changes in relation to the AGT genotype. While no association was observed in the overall population, the study revealed a significant association between the AGT genotype and the response to benazepril in older patients (≥60 years old). Those with the MM genotype experienced a significantly greater reduction in diastolic blood pressure (DBP) compared to those with the MT or TT genotypes. These findings suggest that the AGT genotype may influence the efficacy of benazepril in older hypertensive patients, highlighting the potential for personalized treatment strategies based on genetic variations.

Genetic Variations: A New Frontier in Personalized Medicine

This study demonstrates the growing importance of considering genetic variations in tailoring treatment strategies for individual patients. The findings suggest that the AGT genotype may influence the effectiveness of antihypertensive medications, particularly in older individuals. This underscores the need for further research exploring the role of genetics in drug response and the potential for personalized medicine.

Optimizing Blood Pressure Management: A Holistic Approach

This research encourages a holistic approach to blood pressure management, considering both lifestyle modifications and tailored pharmacological interventions. By incorporating genetic factors into treatment decisions, healthcare providers can potentially improve patient outcomes and optimize medication selection. It's like a camel navigating a desert – understanding the terrain and the individual's needs is essential for reaching the destination.

Dr.Camel's Conclusion

This study is a reminder that even in the vast desert of human biology, there are hidden pathways that can impact our health. Understanding genetic variations like the AGT genotype can help us tailor treatments to individual needs and optimize outcomes. It's a journey of discovery, just like a camel searching for a hidden oasis in the desert.

Date :
  1. Date Completed 2010-02-16
  2. Date Revised 2012-11-15
Further Info :

Pubmed ID

16266458

DOI: Digital Object Identifier

16266458

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.